Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM
Launched by UNIVERSITI PUTRA MALAYSIA · Sep 6, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of date seed extract on controlling diabetes and reducing heart disease risk in people with Type 2 Diabetes Mellitus (T2DM). Researchers want to determine if including date seeds in the diet can help manage blood sugar levels and improve heart health, especially since diabetes is becoming more common in Saudi Arabia. The trial is currently looking for participants aged 18 and older who have been diagnosed with T2DM and are receiving regular diabetes care. Eligible candidates should have stable blood sugar levels and no recent hospitalizations related to their diabetes.
Participants in this trial can expect to take part in a randomized controlled study, which means they might receive either the date seed extract or a placebo (a non-active treatment) without knowing which one they are getting. This helps researchers find out how effective the date seed extract really is. Before joining, potential participants will be screened for certain criteria, such as not being pregnant, having no severe heart or kidney issues, and not having allergies to date products. This trial offers a chance to contribute to important research that could help improve diabetes management for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years old and above.
- • Diagnosis of Type 2 diabetes.
- • Receiving and monitoring diabetes care from diabetes center.
- • With stable HbA1c less than 10% (no episode of hypoglycaemia, no hospitalisation, no change in type or dosage of medication use for at least 6 months).
- Exclusion Criteria:
- • Pregnant or lactating women.
- • Diagnosis of cardiac failure or/and severe renal disease, with physical or mental disability, neurological or cognitive impairment.
- • Participant with severely impaired vision, hearing, or speech.
- • Participants who have known allergy to dates products.
About Universiti Putra Malaysia
Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Serdang, Selangor, Malaysia
Patients applied
Trial Officials
Zuriati Ibrahim, PhD
Principal Investigator
UniversitI Putra Malaysia (UPM), 43400 Serdang, Selangor, Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported